You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Moodys
Medtronic
McKinsey
Mallinckrodt

Last Updated: July 11, 2020

DrugPatentWatch Database Preview

Formulation information for generic ingredient: deferasirox


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Deferasirox

CASRN: 201530-41-8

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
Mallinckrodt
Moodys
Colorcon
Dow